MELI stock · REPL stock

MELI vs REPL · P/E 43, rev $20.78B vs $825.7M cap

MercadoLibre Inc. (MELI) versus Replimune Group Inc (REPL) — a side-by-side from cached financials, not a winner call.

MercadoLibre Inc. (MELI) is a internet retail company listed on NASDAQ.

Replimune Group Inc (REPL) is a biotechnology company listed on NASDAQ.

Latest reported MELI revenue for 2024-12-31 was $20.78B. Net income was $1.91B. Revenue was up 387.6% from 2023-12-31 to 2024-12-31. MELI currently screens at market cap $82.73B and trailing P/E 43.1.

REPL does not have a complete income-statement cache yet.

MELI currently screens at market cap $82.73B and trailing P/E 43.1. REPL currently screens at market cap $825.7M.

Not investment advice. Open the MELI and REPL stock pages for the full models.

Not investment advice.

Popular Stock Comparisons